All Type of News
Cialis increases market share
Cialis, multinational pharmaceutical firm Eli Lilly and Company’s erectile dysfunction drug, is expanding its share of the domestic anti-impotence drug market dominated by Pfizer’s Viagra, an industry report said rece...
Boryung eying sales of 100 billion won with new drug
Boryung Pharmaceutical Co. said its 74 newly recruited salespersons have been under intensive product training for Kanarb (fimasartan), a new drug for hypertension.
The company filed an application with the country...
CreaGene to initiate phase 2 study for liver cancer vaccine
CreaGene Inc., an affiliated company of Choongwae Pharm, said on September 7 that it will conduct its local phase 2 clinical trials for CreaVax-HCC Inj. in five university hospitals, including Seoul National Universit...
Green Cross, Samil to join forces in OTC products
Green Cross Corp. and Samil Pharm have agreed to join hands to market Samil’s Tiersilonce (terbinafine), a potent athlete’s foot treatment and artificial tear solution EYE2O, it was learned on September 5.
Tiersilo...
Innovative and generic drugs to be hit by price cuts in October
The government says its price cut proposals for insurance covered drugs will be implemented in October as originally planned, after completion of cost-effectiveness analysis and set a standard price based on the resul...
KFDA to amend drug master file system by phase
The Korea Food and Drug Administration plans to overhaul the current drug master file system by 2015 in a bid to ensure the international harmonization of drug related application documents.
Under the newly revised...
Korea to invest 55.2 billion in health and medical R&D in latter half
The government plans to invest a total of 55.2 billion won in the second half of this year to nurture the local health and medical sector through research and development (R&D) projects. The plan was unveiled by the M...
KFDA to support off-label use of medications
The Korea Food and Drug Administration plans to provide a variety of incentives to an applicant intends to initiate new clinical trials of off-label drugs to generate additional data for approval agencies to expand in...
Novartis Korea executive to head Genzyme Korea
Genzyme Korea said it has recently appointed Novartis Korea’s general manager Bae Kyung-eun as the president of Genzyme Korea.
As a graduate of Seoul National University pharmacy college, Bae, 40, first joined Nova...
Concept of fair trade code still novel to local large hospitals
Some of local large hospitals are being criticized for breaching the country’s fair trade law as they are said to ask a detailed invoice for supplied drugs including unit price and wholesaler margins.
Critics say t...
